Takeharu Yamanaka

Yamanaka in 2024 is a Japanese politician and current mayor of Yokohama, the capital of Kanagawa Prefecture. He defeated incumbent mayor Fumiko Hayashi in the 2021 Yokohama mayoral election. His independent campaign was supported by the Constitutional Democratic Party, Social Democratic Party, and the Communist Party of Japan. Yamanaka's campaign focused on the opposition for a planned integrated resort development and casino for the city which was to be built on Yamashita Pier, criticism against the government's response to the COVID-19 pandemic, and additional sister city relationship with San Francisco, California.

Yamanaka formerly worked as a professor at Yokohama City University and as a data scientist.

On 16 January 2026, Yamanaka issued a public apology after Yokohama's human resource chief, Jun Kubota, accused Yamanaka of using terms such as "idiot" and "human scum" to disparage staff. Provided by Wikipedia
Showing 1 - 3 results of 3 for search 'Takeharu Yamanaka', query time: 0.02s Refine Results
  1. 1
    Comparing the effects of tofogliflozin and pioglitazone in non-alcoholic fatty liver disease patients with type 2 diabetes mellitus (ToPiND study): a randomized prospective open-label controlled trial

    Comparing the effects of tofogliflozin and pioglitazone in non-alcoholic fatty liver disease patients with type 2 diabetes mellitus (ToPiND study): a randomized prospective open-la... by Atsushi Nakajima, Takeharu Yamanaka, Yasushi Honda, Kento Imajo, Masataka Taguri, Masato Yoneda, Yuji Ogawa, Takaomi Kessoku, Takashi Kobayashi, Anna Ozaki, Asako Nogami, Hiroyuki Kirikoshi, Tomoyuki Iwasaki, Takeo Kurihashi, Satoru Saito

    Published 2021-03-01
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    Rationale and design of a randomised, double-blind, placebo-controlled, parallel-group, investigator-initiated phase 2a study to investigate the efficacy and safety of elobixibat in combination with cholestyramine for non-alcoholic fatty liver disease

    Rationale and design of a randomised, double-blind, placebo-controlled, parallel-group, investigator-initiated phase 2a study to investigate the efficacy and safety of elobixibat i... by Atsushi Nakajima, Takeharu Yamanaka, Koji Yamamoto, Yasushi Honda, Kento Imajo, Masato Yoneda, Yuji Ogawa, Takaomi Kessoku, Takashi Kobayashi, Anna Ozaki, Satoru Saito, Michihiro Iwaki, Yusuke Saigusa, Haruki Usuda, Koichiro Wada

    Published 2020-09-01
    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    Incidence of cancer-associated thromboembolism in Japanese gastric and colorectal cancer patients receiving chemotherapy: a single-institutional retrospective cohort analysis (Sapporo CAT study)

    Incidence of cancer-associated thromboembolism in Japanese gastric and colorectal cancer patients receiving chemotherapy: a single-institutional retrospective cohort analysis (Sapp... by Naoya Sakamoto, Ayane Oba Aonuma, Michio Nakamura, Kentaro Sakamaki, Taichi Murai, Chika Matsuda, Kazufumi Itaya, Takayuki Sone, Masataka Yagisawa, Yuta Koike, Ayana Endo, Yoko Tsukuda, Yuji Ono, Atsushi Nagasaka, Shuji Nishikawa, Takeharu Yamanaka

    Published 2019-08-01
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: